The global bio-photonics market is forecast by SPIE, the international society for optics and photonics, to reach $100bn by 2018. Biophotonic technologies have the potential for a wide range of applications in the diagnosis and treatment of many serious diseases, including cancer, cardiovascular conditions, neurodegenerative diseases, diabetes and impaired vision. Healthcare technologies based on photonics can enable less invasive procedures for eye surgery, retinal mapping, and more general surgery ranging from angioplasty to skin treatments. Imaging and spectroscopy enable real-time procedures for both in-vivo-analysis and in-vitro diagnostics. Photonic manufacturing technologies allow the production of complicated 3D shapes to a high level of accuracy.
SU2P has strengths across the Photonics for Health and Medicine including: optical imaging, optical tweezers, organic LEDs, optogenetics, neurophotonics, lasers for manufacturing, retinal imaging and photoporation.